Krebz Healthcare Profile
Key Indicators
- Authorised Capital ₹ 9.00 M
as on 07-12-2024
- Paid Up Capital ₹ 9.00 M
as on 07-12-2024
- Company Age 20 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 3.00 M
as on 07-12-2024
- Revenue 154.81%
(FY 2022)
- Profit 109.00%
(FY 2022)
- Ebitda 138.73%
(FY 2022)
- Net Worth 25.25%
(FY 2022)
- Total Assets 25.01%
(FY 2022)
About Krebz Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 9.00 M and a paid-up capital of Rs 9.00 M.
The company has closed loans amounting to ₹3.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Ramu Kumar, Sekar Chettiar, and Baalachandar Sekar serve as directors at the Company.
- CIN/LLPIN
U24231TN2004PTC052617
- Company No.
052617
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Feb 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Tiruvallur, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Krebz Healthcare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramu Kumar  | Director | 30-Apr-2016 | Current |
| Sekar Chettiar | Director | 02-Jun-2024 | Current |
| Baalachandar Sekar | Director | 02-Jun-2024 | Current |
Financial Performance of Krebz Healthcare.
Krebz Healthcare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 154.81% increase. The company also saw a substantial improvement in profitability, with a 109% increase in profit. The company's net worth Soared by an impressive increase of 25.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Krebz Healthcare?
In 2022, Krebz Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Chennai Oscar Bio Pharmaceuticals Private LimitedActive 11 years 8 months
Sekar Chettiar and Baalachandar Sekar are mutual person
- Om Dhan Naturals Private LimitedActive 3 years 3 months
Sekar Chettiar and Baalachandar Sekar are mutual person
- Guruv Pharmaceutical Private LimitedActive 5 years 22 days
Sekar Chettiar and Baalachandar Sekar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Andhra Bank Creation Date: 12 Jan 2007 | ₹3.00 M | Satisfied |
How Many Employees Work at Krebz Healthcare?
Unlock and access historical data on people associated with Krebz Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Krebz Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Krebz Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
